White Paper

Report: Impacts Of Decentralized Clinical Trials 2021

iStock-1163081129-doctor-clinical-study

Decentralized clinical trials have had the potential to revolutionize studies for a number of years, though in the last two years, accelerated by COVID-19, they have finally started to realize some of that potential.

However, to what extent have decentralized trials – and associated elements of Home Trial Support (home trial HcP/nurse visits and VCT/remote technology) – been adopted in the industry? And what are the true impacts on speed, patient recruitment and retention, cost and patient-centricity?

Clinical Trials Europe in partnership with MRN, conducted a huge survey of clinical trials professionals around the world to answer these questions. This final report based on 125 responses reveals unique insights into the adoption of decentralized trials today.

access the White Paper!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

MRN - Medical Research Network